2025 Research Grant Call now open!
We are delighted to open a research grant call for 2025. Thanks to the support of our fantastic donors and supporters, we are now able
We are delighted to open a research grant call for 2025. Thanks to the support of our fantastic donors and supporters, we are now able
📣 Calling all businesses and community groups across Altrincham! 📣 This September, we’re turning up the energy across Altrincham in support of Active Altrincham month
We’re proud to be taking part in Volunteers’ Week 2025 – marking 41 years of saying thank you to all volunteers across the UK for
A massive congratulations and thank you to Matt Freeman, who ran the Riga Half Marathon last weekend for the Children’s Cancer Research Fund, raising a
A huge THANK YOU to the Rolls Royce Social Committee for their recent donation to our charity. For small charities like ours, company and community support
A huge thank you to all our Easter egg raffle holders this year. Together, they raised over £2,000 for vital children’s cancer research projects. Thanks
At the start of January, Dr Amy Chadwick and Dr Emma Biglin began the second year of a research project funded by the Children’s Cancer
Joining as a Scientific Trustee We are delighted to welcome Professor John Hickman to our Board of Trustees. John joins us as our Scientific Trustee,
Inspiring the next generation of medical researchers Every year on 8 March the world comes together to celebrate International Women’s Day, an occasion dedicated to
© 2025 Children’s Cancer Research Fund | Charity No. 1046278 | Website by ATTAIN.
John Hickman was the ICI Professor of Molecular Pharmacology at the University of Manchester. After a postdoctoral fellowship at the Institute of Cancer Research London, he held University posts in Liverpool, Birmingham and Manchester and as a visiting scientist at Yale University. He was the lead pharmacologist for the discovery of the drug Temozolomide, used to treat brain cancers. Professor Hickman moved to Paris in 2000 to direct cancer drug discovery at Servier. He retired in 2010 and then coordinated a European Union Innovative Medicines Initiative (IMI) consortium. From 2016 – 2022, John was Chair of the Friends of Rosie SAB. In 2022, he hosted the first of a series of international childhood cancer research symposiums for Friends of Rosie.
Katrina has specialised in the field of occupational personal injury for over 35 years and has worked exclusively for the victims of asbestos related diseases for the last 20 years. Katrina is an APIL Accredited Occupational Disease and Asbestos Disease Specialist and Senior Litigator and has Law Society Personal Injury Accreditation.
Carla has over 20 years’ experience specialising in strategic communications, engagement and marketing across the public and private sector, including the BBC, Manchester Metropolitan University and Muse Developments. She is currently Executive Director of Corporate Affairs and Marketing for The Growth Company, an award-winning social enterprise that enables growth, creates jobs and improves lives.
